ABSTRACT
Background: Physical distancing under the coronavirus disease 2019 (COVID-19) pandemic had a significant impact on lifestyles, including exercise routines. In this study, we examined the difference of tendency of addictive behaviors, such as excessive exercise and the usage of the image and performance-enhancing drug (IPED) across 12 sport disciplines Method: A large cross-sectional sample of the adult population (N= 2,295) was surveyed. The use of IPED was assessed in conjunction with psychometric measures such as the Exercise Addiction Inventory (EAI) and the Appearance Anxiety Inventory (AAI). The participants were grouped into activity group (AG) and non-activity group (NAG) according to the presence or absence of their exercise habits. The results were compared between these groups, as well as across sport disciplines. Results: The frequency of IPEDs use was higher among AG (34.6%) than NAG (14.6%). The logistic regression analysis revealed that scores equal to or above cutoff points, in both the EAI and AAI, predicted the IPED use. Regarding the differences across the various sports disciplines, those who were involved in practicing Weight Lifting and Cross-Fit were found to be more at risk of excessive exercising and more inclined to use a wide range of IPED. Conversely, those who were engaged in walking is low EAI as well as a low rate of IPED use. Conclusions: These results may indicate that excessive exercise is associated with the risk of cross-addiction with substance intake, particularly in disciplines that demand high-intensity functional training.
ABSTRACT
Background: The literature has been showing evidence about the impact of restrictive measures during the COVID-19 pandemic on different psychological variables and behaviours. This study aims to assess the contribution of anxiety about appearance on the practice of physical exercise and use of image-and performance-enhancing drugs (IPEDs) during the COVID-19 lockdown. Method: An online survey was carried out comprising the Exercise Addiction Inventory, and the Appearance Anxiety Inventory in addition to questions on the use of IPEDs. Results: The sample consisted of 3.161 (65% female) adults from seven countries (Italy, Spain, the United Kingdom [UK], Lithuania, Portugal, Japan and Hungary). Mean age was 35.05 years (SD = 12.10). Overall, 4.3% of the participants were found to engage in excessive or problematic exercise during the COVID-19 lockdown with peaks registered in the UK and Spain. Participants across all countries also reported the use of drugs and medicines to boost image and performance, and this use was maintained or started during the lockdown. Significant appearance anxiety levels were found across the sample. Logistic regression models revealed that anxiety about appearance was a non-significant predictor of engaging in physical exercise but increased the probability of using IPEDs significantly. This was despite the strong association found between physical exercise and IPEDs use. Conclusions: This study identified risks of appearance anxiety associated with the unsupervised use of IPEDs among the general population during the COVID-19 lockdown period across all the participating countries. The risks of appearance anxiety associated with excessive physical exercising were non-significant.
ABSTRACT
Symposium summary: The current COVID-19 pandemic has been affecting the body image of individuals as well as their practice of physical exercise and their consumption of image-and performance-enhancing drugs (IPEDs) in an attempt to boost their appearance. This symposium will present the results of various cross-sectional studies that are part of an overarching global project aimed to study fitness habits during the COVID-19 lockdown which was carried out in eight countries (UK, Portugal, Spain, Italy, Hungary, Lithuania, Brazil, and Japan). These studies focus on: (1) Assessing the perception of body image during self-isolation;(2) Exploring the practice of exercising and related habits during self-isolation (e.g., using fitness apps or spending more time in social media);(3) Understanding whether exercise can help to cope with self-isolation;and (4) Exploring any potential use of IPEDs during self-isolation as a way to boost physical appearance. Findings have contributed to a better understanding of the effects of self-isolation on body image and the identification of related risky behaviours in the attempt to boost physical appearance, while contributing to the development of practices targeting mental and physical wellbeing in challenging times for humanity.
ABSTRACT
Background: Experts in the field raised concerns about the rise of the Problematic Usage of the Internet (PUI) during the Coronavirus pandemic (COVID-19), however, specific online behaviours and how they are presented cross-culturally were explored to a lesser extent. In this study, we aimed to explore the cross-cultural manifestation of specific online behaviours and their associations with self-compassion, appearance anxiety, image and performance enhancing drugs (IPEDs) use, and specific online behaviours. Methods: An international survey was conducted in eight countries including Italy, Lithuania, Portugal, Spain, Japan, United Kingdom, Brazil and Hungary comprising in total 2223 individuals with a mean age of 33±11 years old. Participants were surveyed for specific type of Internet use severity (the Internet Activities Scale from the Internet Severity and Activities Addiction Questionnaire), selfcompassion (the Self-Compassion Scale, SCS), appearance anxiety (the Appearance Anxiety Inventory, AAI), and IPEDs use. Results: After adjustment for demographic factors, hours online, and country, self-compassion remained associated with higher levels of skill games and time wasters (β=-.073;p<.002), streaming (β=-.053;p=.018), digital hoarding (β=-.065;p=.006) and cyberchondria (β=-.153;p<.001). Appearance was associated with general surfing (β=.136;p<.001), online shopping (β=.137;p<.001), online gambling (β=.067;p=.003), social networking (β=.131;p<.001), pornography use (β=.102;p<.001), digital hoarding (β=.079;p<.001) and cyberchondria (β=.120;p<.001). IPEDs use also remained associated with various online behaviours during the COVID-19 pandemic Conclusions: Our exploratory study demonstrates that self-compassion, appearance anxiety, and IPEDS use contribute to various forms of PUI.
ABSTRACT
Objectives: Elexacaftor/tezacaftor/ivacaftor (ETI) combination therapy - Kaftrio® was approved for use in the UK in August 2020 for those aged >12 years. Our study aimed to study the effects of ETI therapy on lung function and exercise performance. Methods: Two-centre retrospective analysis of clinical data obtained during patients’ annual review assessments. Patients had undergone spirometry and static lung volume measurements followed by an incremental maximal ramp cardiopulmonary exercise testing (CPET) performed on a cycle ergometer. Data were analysed using a paired sample t-test. Results: Lung function improvement did not reach statistical significance. Of note, four patients had a baseline (pre-ETI) FEV1 belowthe lower limit of normal (LLN <-1.64 Z scores), and one improved their FEV1 from 41% predicted to 87% with Kaftrio®. Five had a VO2peak% predicted below the LLN (< 85% predicted) prior to treatment and 8 post treatment. Therewas a significant fall in VO2peak % predicted, p = 0.03. However, this was not seen in the VO2peak relative to bodyweight, p = 0.07. There was also a significant fall in VO2 at anaerobic threshold (AT) as a % of predicted VO2peak, p = 0.01. Table 1. (Table Presented) (Table Presented) Conclusions: This real-world study suggests Kaftrio® does not improve exercise capacity in the majority of CF patients. It is hypothesised that the lack of improvement may be due to a reduced physical activity over the study period as a result of feeling better on Kaftrio® and also the SARSCoV2 pandemic. The decrease in VO2 at AT would support the hypothesis of physical deconditioning. The reasons for not seeing statistical differences in lung function are likely to represent the relatively high baseline FEV1 alongside small study numbers. In summary, whilst having the potential to be a performance-enhancing drug, performance gains on Kaftrio® can only occur if matched by training, and studies to investigate the training potential of Kaftrio® are required.